This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
August 14, 2024
Oncopeptides publishes Q2 report 2024
August 12, 2024
Spruce Biosciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
August 12, 2024
Aprea Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
August 08, 2024
Carisma Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
August 08, 2024
Oncopeptides – Invitation to presentation of the Q2 report 2024
August 06, 2024
Carisma Therapeutics Announces Expansion of Its Scientific Advisory Board
July 31, 2024
Pulmonx Reports Second Quarter 2024 Financial Results
July 28, 2024
Ariceum Therapeutics Commences Phase 1 Clinical Trial in Patients with Recurrent Glioblastoma
July 27, 2024
HealthCap senior advisor Bengt Samuelsson has passed away at the age of 90
July 22, 2024
First patient enters Oncopeptides study aiming to gain real-world insights from Pepaxti in Germany